Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zirconium Silicate in CKD with Mild Hyperkalemia
NCT01493024Phase 2Completed
- Sponsor
- ZS Pharma
- Start
- Nov 2011
- Primary completion
- May 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sodium zirconium cyclosilicate in hyperkalemia (4 arms), sponsored by ZS Pharma. Primary endpoint: Difference in the Exponential Rate of Change in Serum Potassium Levels Versus Placebo at 48 hours. Started Nov 2011; status: completed.
02
Drugs
sodium zirconium cyclosilicate
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT01493024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01493024.